Dynavax Technologies Corporation
2 products found

Dynavax Technologies Corporation products

Hepatitis B Vaccine (Recombinant) Adjuvanted

HEPLISAV-B is indicated for prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.1


Cutting-Edge Vaccines

We believe the immune system is a valuable and critical tool that can be harnessed to prevent and treat disease. We are developing cutting-edge vaccines based on Toll-like Receptor (TLR) biology and its ability to control and modulate the immune system.